A Study for Treatment of Pain in Patients With Diabetic Neuropathy.

NCT00785577 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG: Placebo
DRUG: Pregabalin
DRUG: LY545694 21 mg
DRUG: LY545694 49 mg
DRUG: LY545694 105 mg

Sponsor

Eli Lilly and Company